Found: 146
Select item for more details and to access through your institution.
Are there Neuropsychological Predictors for Response and Nonresponse in First-Episode Drug Naïve Patients with OCD? A 12 Weeks Interventional Study.
- Published in:
- Annals of Indian Psychiatry, 2023, v. 7, n. 4, p. 303, doi. 10.4103/aip.aip_110_22
- By:
- Publication type:
- Article
Patient Information Sheet.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2023, v. 25, n. 8, p. 9, doi. 10.1002/cpu.30797
- Publication type:
- Article
Treatment in Children and Adolescents With Obsessive-Compulsive Disorder: Review for Practitioners.
- Published in:
- Journal of Psychosocial Nursing & Mental Health Services, 2023, v. 61, n. 8, p. 11, doi. 10.3928/02793695-20230705-02
- By:
- Publication type:
- Article
Reasons for Discontinuation or Change of Selective Serotonin Reuptake Inhibitors in Online Drug Reviews.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 7, p. e2323746, doi. 10.1001/jamanetworkopen.2023.23746
- By:
- Publication type:
- Article
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2023, v. 34, n. 7, p. 9, doi. 10.1002/pu.31042
- Publication type:
- Article
Obsessive-Compulsive Disorder during the COVID-19 Pandemic.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a reduced risk of subsequent hospitalization and death compared to their non-prescribed peers: population-based matched cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 5, p. 643, doi. 10.1007/s00228-023-03479-3
- By:
- Publication type:
- Article
Drugs to Treat Anxiety Disorders and Obsessive Compulsive Disorder (OCD).
- Published in:
- Journal of Psychosocial Nursing & Mental Health Services, 2023, v. 61, n. 5, p. 5, doi. 10.3928/02793695-20230324-79
- Publication type:
- Article
Why we should not recommend or offer fluvoxamine to COVID-19 patients?
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Treatment with fluvoxamine in nonhospitalized coronavirus disease 2019 patients.
- Published in:
- Egyptian Journal of Chest Diseases & Tuberculosis, 2023, v. 72, n. 1, p. 40, doi. 10.4103/ecdt.ecdt_38_22
- By:
- Publication type:
- Article
Fluvoxamine and other drugs fail to prevent complications in COVID‐19 patients.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 12, p. 8, doi. 10.1002/pu.30955
- Publication type:
- Article
Clomipramine as an alternative to selective serotonin reuptake inhibitors for patients at haemorrhagic risk.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Patient Information Sheet.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2022, v. 24, n. 8, p. 9, doi. 10.1002/cpu.30700
- Publication type:
- Article
Fluvoxamine-induced tics: A rare phenomenon.
- Published in:
- Archives of Medicine & Health Sciences, 2022, v. 10, n. 2, p. 274, doi. 10.4103/amhs.amhs_207_22
- By:
- Publication type:
- Article
A case of iatrogenic psychosis in the context of inappropriate prescribing for COVID-19.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Ivermectin and the TOGETHER Trial.
- Published in:
- Regulation, 2022, v. 45, n. 2, p. 2
- By:
- Publication type:
- Article
Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-analysis.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 4, p. e226269, doi. 10.1001/jamanetworkopen.2022.6269
- By:
- Publication type:
- Article
Abstract- Poster.
- Published in:
- 2022
- Publication type:
- Abstract
Comment on: "Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence".
- Published in:
- 2022
- By:
- Publication type:
- Letter
Authors' Reply to Mazza et al.: "Fluvoxamine for the Early Treatment of SARS‑CoV‑2 Infection: A Review of Current Evidence".
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Fluvoxamine lowers hospitalization risk in patients with COVID‐19.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 2, p. 6, doi. 10.1002/pu.30829
- Publication type:
- Article
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence.
- Published in:
- Drugs, 2021, v. 81, n. 18, p. 2081, doi. 10.1007/s40265-021-01636-5
- By:
- Publication type:
- Article
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 11, p. e2133090, doi. 10.1001/jamanetworkopen.2021.33090
- By:
- Publication type:
- Article
Do the Selective Serotonin Reuptake Inhibitor Antidepressants Fluoxetine and Fluvoxamine Reduce Mortality Among Patients With COVID-19?
- Published in:
- 2021
- By:
- Publication type:
- Opinion
Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia.
- Published in:
- Indian Journal of Psychiatry, 2021, v. 63, n. 6, p. 613, doi. 10.4103/indianjpsychiatry.indianjpsychiatry_206_21
- By:
- Publication type:
- Article
A Covid-19 klinikai kimenetelének súlyosságát nemcsak a pszichiátriai kórállapot, hanem a pszichiátriai gyógyszerelés is befolyásolja.
- Published in:
- Lege Artis Medicine (LAM), 2021, v. 31, n. 8/9, p. 357, doi. 10.33616/lam.31.027
- By:
- Publication type:
- Article
Patient Information Sheet.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2021, v. 23, n. 7, p. 9, doi. 10.1002/cpu.30596
- Publication type:
- Article
Gastroprotective effect of fluvoxamine and ondansetron on stress-induced gastric ulcers in mice.
- Published in:
- Journal of Basic & Clinical Physiology & Pharmacology, 2021, v. 32, n. 4, p. 485, doi. 10.1515/jbcpp-2020-0424
- By:
- Publication type:
- Article
Roux-en-Y Gastric Bypass and Antipsychotic Therapeutic Drug Monitoring: Two Cases.
- Published in:
- Journal of Pharmacy Practice, 2021, v. 34, n. 3, p. 503, doi. 10.1177/0897190020905467
- By:
- Publication type:
- Article
Homozygosity for rs17775810 Minor Allele Associated With Reduced Mortality of COVID-19 in the UK Biobank Cohort.
- Published in:
- In Vivo, 2021, v. 35, n. 2, p. 965, doi. 10.21873/invivo.12338
- By:
- Publication type:
- Article
Russell's sign in obsessive--compulsive disorder.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Evaluation of Oxidant-Antioxidant Status of Fluvoxamine on Human Lymphocyte Cell Culture.
- Published in:
- Hittite Journal of Science & Engineering, 2021, v. 8, n. 1, p. 79, doi. 10.17350/HJSE19030000216
- By:
- Publication type:
- Article
A holistic psychotherapeutic approach for the management of obsessive-compulsive disorder with poor insight.
- Published in:
- Journal of Mental Health & Human Behavior, 2021, v. 26, n. 1, p. 78, doi. 10.4103/jmhhb.jmhhb_56_20
- By:
- Publication type:
- Article
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2020, v. 324, n. 22, p. 2292, doi. 10.1001/jama.2020.22760
- By:
- Publication type:
- Article
COVID-19 Infection-Preventing Clinical Deterioration.
- Published in:
- JAMA: Journal of the American Medical Association, 2020, v. 324, n. 22, p. 2300, doi. 10.1001/jama.2020.21720
- By:
- Publication type:
- Article
Patient Information Sheet.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2020, v. 22, n. 8, p. 9, doi. 10.1002/cpu.30516
- Publication type:
- Article
Lithium Intoxication in the Elderly: A Possible Interaction between Azilsartan, Fluvoxamine, and Lithium.
- Published in:
- Innovations in Clinical Neuroscience, 2020, v. 17, n. 4-6, p. 45
- By:
- Publication type:
- Article
Clinically relevant drug interactions between statins and antidepressants.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 2, p. 227, doi. 10.1111/jcpt.13058
- By:
- Publication type:
- Article
SSRIs vs. SNRIs for anxiety and OCD.
- Published in:
- Brown University Child & Adolescent Behavior Letter, 2020, v. 36, n. 3, p. 3, doi. 10.1002/cbl.30448
- By:
- Publication type:
- Article
Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 12, p. 1620, doi. 10.1002/jcph.1453
- By:
- Publication type:
- Article
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2019, v. 30, n. 11, p. 9, doi. 10.1002/pu.30419
- Publication type:
- Article
Hypertension induced by serotonin reuptake inhibitors: analysis of two pharmacovigilance databases.
- Published in:
- Fundamental & Clinical Pharmacology, 2019, v. 33, n. 3, p. 296, doi. 10.1111/fcp.12440
- By:
- Publication type:
- Article
Transdermal clonidine for mitigating posttraumatic stress disorder in an adolescent.
- Published in:
- American Journal of Health-System Pharmacy, 2019, v. 76, n. 8, p. 487, doi. 10.1093/ajhp/zxz021
- By:
- Publication type:
- Article
Effects of fluvoxamine on nerve growth factor-induced neurite outgrowth inhibition by dexamethasone in PC12 cells.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2019, v. 83, n. 4, p. 659, doi. 10.1080/09168451.2018.1553607
- By:
- Publication type:
- Article
Fluvoxamine‐methylphenidate combination improves treatment response in OCD.
- Published in:
- Brown University Psychopharmacology Update, 2019, v. 30, n. 4, p. 7, doi. 10.1002/pu.30416
- Publication type:
- Article
Selective serotonin reuptake inhibitor fluvoxamine ameliorates stress- and NSAID-induced peptic ulcer possibly by involving Hsp70.
- Published in:
- Journal of Basic & Clinical Physiology & Pharmacology, 2019, v. 30, n. 2, p. 195, doi. 10.1515/jbcpp-2018-0067
- By:
- Publication type:
- Article
Modulation of the sigma-1 receptor–IRE1 pathway is beneficial in preclinical models of inflammation and sepsis.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 478, p. N.PAG, doi. 10.1126/scitranslmed.aau5266
- By:
- Publication type:
- Article
A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Genetic and pharmacogenetic study of glutamate transporter (SLC1A1) in Iranian patients with obsessive‐compulsive disorder.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2019, v. 44, n. 1, p. 39, doi. 10.1111/jcpt.12766
- By:
- Publication type:
- Article
Treatments used for obsessive–compulsive disorder—An international perspective.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2019, v. 34, n. 1, p. 1, doi. 10.1002/hup.2686
- By:
- Publication type:
- Article